Overview
U.S. ingredient solutions provider's Q1 net sales fell 1% yr/yr
Q1 adjusted EPS missed analyst expectations
Company cut full-year adjusted EPS guidance, citing operational challenges at Argo facility
Outlook
Ingredion sees full-year 2026 reported EPS at $9.60-$10.30 and adjusted EPS at $10.45-$11.15
Company expects 2026 net sales to be flat to up low single-digits, with reported operating income down high single-digits
Result Drivers
ARGO FACILITY ISSUES - Operational challenges and a longer-than-expected recovery at the Argo facility weighed on Food & Industrial Ingredients—U.S./CAN results
SOFTER DEMAND - Lower volumes and less favorable mix in Food & Industrial Ingredients—U.S./CAN contributed to the overall sales decline
TEXTURE & HEALTHFUL SOLUTIONS GROWTH - Continued broad-based net sales volume growth in Texture & Healthful Solutions, driven by strong customer demand
Company press release: ID:nGNXt7PJ8
Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Adjusted EPS
Miss
$2.34
$2.47 (6 Analysts)
Q1 EPS
$2.22
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy", 5 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the food processing peer group is "buy"
Wall Street's median 12-month price target for Ingredion Inc is $126.00, about 17.9% above its May 4 closing price of $106.88
The stock recently traded at 9 times the next 12-month earnings vs. a P/E of 10 three months ago
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)